Triazoles

"Triazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

No definition found.

Descriptor ID	D014230
MeSH Number(s)	D03.383.129.799
Concept/Terms	Triazoles Triazoles

Below are MeSH descriptors whose meaning is more general than "Triazoles".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Triazoles [D03.383.129.799]

Below are MeSH descriptors whose meaning is related to "Triazoles".

Below are MeSH descriptors whose meaning is more specific than "Triazoles".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Triazoles" by people in this website by year, and whether "Triazoles" was a major or minor topic of these publications.

Bar chart showing 73 publications over 25 distinct years, with a maximum of 8 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	2	2
2000	1	0	1
2003	1	2	3
2004	1	0	1
2005	2	0	2
2006	1	1	2
2007	2	0	2
2008	4	0	4
2009	0	1	1
2010	1	1	2
2011	3	1	4
2012	3	2	5
2013	3	0	3
2014	1	1	2
2015	3	1	4
2016	1	2	3
2017	6	2	8
2018	3	2	5
2019	0	1	1
2020	2	0	2
2021	2	0	2
2022	1	5	6
2023	0	2	2
2024	1	4	5
2025	1	0	1

Below are the most recent publications written about "Triazoles" by people in Profiles.

Srour AM, El-Bayaa MN, Temirak A, Alanzy AL, Awad HM, Saleh A, Saleh MG, El-Sayed WA. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025 Jul 15; 15(1):25514.

View in: PubMed
Zhou Z, Guo J, Hetrick B, Tiwari S, Haikerwal A, Han Y, Bond VC, Huang MB, Mankowski MK, Snyder BA, Hogan PA, Sharma SK, Liotta DC, Reid TE, Wilson LJ, Wu Y. Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties. PLoS Pathog. 2024 Aug; 20(8):e1012448.

View in: PubMed
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL. ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. Int J Gynecol Cancer. 2024 08 05; 34(8):1283-1289.

View in: PubMed
Borchardt-Setter KA, Yu J, Stelzer T, Yu L. Surface Enrichment and Depletion of Components in a Ternary Drug-Surfactant-Polymer Amorphous Solid Dispersion. Mol Pharm. 2024 Aug 05; 21(8):4074-4081.

View in: PubMed
Liu W, Mousa AAK, Hopkins AM, Wu YF, Thu KL, Campbell M, Lees SJ, Ramachandran R, Hou J. Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists as Potential Migrastatics for Triple Negative Breast Cancer. ChemMedChem. 2024 Aug 19; 19(16):e202400013.

View in: PubMed
Upadhyay DB, Mokariya JA, Patel PJ, Patel SG, Das A, Nandi A, Nogales J, More N, Kumar A, Rajani DP, Narayan M, Kumar J, Banerjee S, Sahoo SK, Patel HM. Indole clubbed 2,4-thiazolidinedione linked 1,2,3-triazole as a potent antimalarial and antibacterial agent against drug-resistant strain and molecular modeling studies. Arch Pharm (Weinheim). 2024 Apr; 357(4):e2300673.

View in: PubMed
Shikuma CM, Wojna V, De Gruttola V, Siriwardhana C, Souza SA, Rodriguez-Benitez RJ, Turner EH, Kallianpur K, Bolzenius J, Chow D, Matos M, Shiramizu B, Clements DM, Premeaux TA, Ndhlovu LC, Paul R. Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS. 2023 11 01; 37(13):1987-1995.

View in: PubMed
Patel JR, Banjara B, Ohemeng A, Davidson AM, Bou? SM, Burow ME, Tilghman SL. Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 2023 Mar 28; 15(7).

View in: PubMed
Sviatenko LK, Gorb L, Leszczynski J. NTO Degradation by Nitroreductase: A DFT Study. J Phys Chem B. 2022 08 18; 126(32):5991-6006.

View in: PubMed
Luine V, Mohan G, Attalla S, Jacome L, Frankfurt M. Androgens Enhance Recognition Memory and Dendritic Spine Density in the Hippocampus and Prefrontal Cortex of Ovariectomized Female Rats. Neuroscience. 2025 Mar 05; 568:465-475.

View in: PubMed

People

Explore

Similar Concepts

Top Journals